Panganting, Rhynz R.

HRN: 28-09-61  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/18/2026
CEFUROXIME 750MG (VIAL)
01/18/2026
01/25/2026
IV
140mg
Q8
T/c UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: